Serum androgens: Associations with prostate cancer risk and hair patterning

Journal of Andrology

Volumn 18, Issue 5, 1997, Pages 495-500

  Demark Wahnefried, Wendy ^a   Lesko, Samuel M ^b   Conaway, Mark R ^a   Robertson, Cary N ^a   Clark, Richard V ^a   Lobaugh, Bruce ^a   Mathias, Barbara J ^a   Strigo, Tara Smith ^a   Paulson, David F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Baldness; Hormones; Prostatic neoplasms; Testosterone

Indexed keywords

ANDROGEN; ANDROSTANOLONE; TESTOSTERONE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HAIR GROWTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; TESTOSTERONE BLOOD LEVEL;

AGED; ALOPECIA; CONFIDENCE INTERVALS; DIHYDROTESTOSTERONE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REFERENCE VALUES; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0030667960     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bagatell CJ, Bremner WJ. Androgens in men - uses and abuses. N Engl J Med 1996;334:707-714.
2. Barrett-Connor E, Garland C, McPhillips JB, Khaw KT, Wingard DL. A prospective, population-based study of androstenedione, estrogens and prostatic cancer. Cancer Res 1990;50:169-173.
3. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL, Rosner W, Walsh PC. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate 1995;27:25-31.
4. Gann P, Hennekens C, Ma J, Longcope C, Stampfer M. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996;88:1118-1122.
5. Ghanadian R, Puah CM, O'Donoghue EPN. Serum testosterone and dihydrotestosterone in carcinoma of the prostate. Br J Cancer 1979;39: 696-699.
6. Greenwald P, Damon A, Kirmss V, Polan AK. Physical and demographic features of men before developing cancer of the prostate. J Natl Cancer Inst 1974;53:341-346.
7. Hsing AW, Comstock GW. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev 1993;2:27-32.
8. Hulka B, Hammond J, DiFerdinando G, Mickey O, Fried F, Checkoway H. Serum hormone levels among patients with prostatic carcinoma or benign prostatic hyperplasia and clinic controls. Prostate 1987;11: 171-182.
9. Isaacs JT. Role of androgens in prostatic cancer. Vitamins Hormones 1994;49;433-504.
10. Meikle AW, Smith JA, West DW. Familial factors affecting prostate cancer risk and plasma sex-steroid levels. Prostate 1985;6:121-128.
11. NCI Roundtable. National Cancer Institute roundtable on prostate cancer. Cancer Res 1991;51:2498-2520.
12. Nomera A, Heilbrun LK, Stemmermann GN, Judd HL. Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res 1988;48: 3515-3517.
13. Nomera A, Kolonel L. Prostate cancer: a current prospective. Am J Epidemiol 1991;13:200-227.
14. Nomera AMY, Stemmermann GN, Chyou PH, Stanczyk FZ. Serum androgens and prostate cancer. Cancer Epidemiol Biomarkers Prev 1996;5:621-629.
15. Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975;68:1359-1365.
16. Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate 1996;6S:67-73.
17. Oishi K, Okada K, Yoshida O, Yamabe H, Ohno Y, Hayes RB, Schroeder FH. Case-control study of prostatic cancer in Kyoto, Japan: demographic and some lifestyle risk factors. Prostate 1989;14:117-122.
18. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics 1996. CA-A Cancer J Clin 1996;46:5-27.
19. Randall VA. Androgens and human hair growth. Clin Endocrinol 1994; 40:439-457.
20. Wynder EL, Mabuchi K, Whitmore WF Jr. Epidemiology of the prostate. Cancer 1971;28:344-360.
21. Zumoff B, Levin J, Strain GW, Rosenfeld RS, O'Connor J, Freed SZ, Kream J, Whitmore WS, Fukushima DK, Hellman L. Abnormal levels of plasma hormones in men with prostate cancer: evidence toward a "two-disease" theory. Prostate 1982;3:579-588.